- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 12.03. | Dicot Pharma AB: Dicot Pharma initiates tablet manufacturing ahead of phase 2b clinical study | 167 | GlobeNewswire (Europe) | Uppsala, Sweden, March 12, 2026. Dicot Pharma AB announces that the company has successfully completed the development of LIB-01 as a tablet and initiated manufacturing of tablets ahead of the upcoming... ► Artikel lesen | |
| 18.12.25 | Dicot Pharma AB: Dicot Pharma signs agreement with CRO ahead of phase 2b study with LIB-01 | 431 | GlobeNewswire (Europe) | Uppsala, Sweden, December 18, 2025. Dicot Pharma AB has signed an agreement with a global contract research organization (CRO) to prepare for the planned phase 2b clinical study of the drug candidate... ► Artikel lesen | |
| 23.10.25 | Dicot Pharma AB Q3 Sales Decline | 4 | RTTNews | ||
| 23.10.25 | Dicot Pharma AB: Dicot Pharma Announces Positive Results from its Phase 2a Study | 393 | GlobeNewswire (Europe) | Uppsala, Sweden October 23, 2025. Today, Dicot Pharma announces positive topline results from its phase 2a study of LIB-01 for the treatment of erectile dysfunction. The outcomes demonstrated clinically... ► Artikel lesen | |
| 27.08.25 | Dicot Pharma AB: Dicot Pharma included in global stock index | 374 | GlobeNewswire (Europe) | Uppsala, Sweden, August 27, 2025. As of today, the Swedish, erectile dysfunction drug developer Dicot Pharma has been incorporated into the MSCI Global Micro Cap Index, managed by MSCI, the world's... ► Artikel lesen | |
| 20.08.25 | Dicot Pharma AB: Dicot Pharma's Phase 2a study completed - results within three months | 346 | GlobeNewswire (Europe) | Uppsala, Sweden, August 20, 2025. Today, potency drug developer Dicot Pharma announces that the clinical part of its phase 2a study has been completed, as the final participant now has completed the... ► Artikel lesen | |
| DICOT PHARMA Aktie jetzt für 0€ handeln | |||||
| 12.08.25 | Dicot Pharma AB: Dicot Pharma presents interim report Q2 2025 | 361 | GlobeNewswire (Europe) | Uppsala, Sweden, August 12, 2025. Dicot Pharma AB publishes its interim report for the second quarter of 2025. The report is available as an attached document and on www.dicotpharma.com. The company's... ► Artikel lesen | |
| 29.04.25 | Dicot Pharma AB: Dicot Pharma presents interim report Q1 2025 | 388 | GlobeNewswire (Europe) | Uppsala, Sweden, April 29, 2025. Dicot Pharma AB publishes its interim report for the first quarter of 2025. The report is available as an attached document and on www.dicotpharma.com. The company's... ► Artikel lesen |
8 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| KHIRON LIFE SCIENCES | 0,029 | -100,00 % | Khiron Life Sciences Corp: Khiron Life Sciences warrants to expire Nov. 26 | ||
| CHRISTINA LAKE CANNABIS | 0,014 | +50,00 % | Christina Lake Cannabis Corp: Christina Lake investor Milia acquires 5.03M shares | ||
| PSYCHED WELLNESS | 0,005 | +12,50 % | Psyched Wellness Ltd.: Psyched Wellness Announces Closing of Private Placement and Shares for Debt Transaction and Resignation of a Director | Toronto, Ontario--(Newsfile Corp. - March 20, 2026) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company"), a life sciences company focused on the production and distribution... ► Artikel lesen | |
| MOLECULE HOLDINGS | 0,001 | 0,00 % | Molecule Holdings Inc. Provides Corporate Update | ||
| NUMINUS WELLNESS | 0,027 | -100,00 % | Numinus Wellness Inc.: Numinus Wellness Provides Update Regarding Listing Status | Vancouver, British Columbia--(Newsfile Corp. - March 24, 2026) - Numinus Wellness Inc. (TSX: NUMI) (OTC Pink: NUMIF) ("Numinus" or the "Company"), a mental health care company focused on innovative... ► Artikel lesen | |
| BETTERLIFE PHARMA | 0,031 | -6,06 % | BetterLife Pharma Inc. - 6-K, Report of foreign issuer | ||
| MEDIPHARM LABS | 0,037 | -11,90 % | MediPharm Labs Corp.: MediPharm Labs Reports Full Year & Fourth Quarter 2025 Results with Over 40% Annual Growth in International Medical Revenue | FY 2025 revenue of $45.1 million, an increase of 8% over 2024International Medical Cannabis revenue increased 43% year-over-year and represented more than 50% of total revenueIncreased cash balance... ► Artikel lesen | |
| PROMINO NUTRITIONAL SCIENCES | 0,017 | 0,00 % | Promino Nutritional Sciences, Inc.: Promino Nutritional Sciences Launches NCAA Division I Athlete Platform Through Multi-Sport NIL Partnership with Virginia Military Institute | Burlington, Ontario--(Newsfile Corp. - April 9, 2026) - Promino Nutritional Sciences, Inc. (CSE: MUSL) (OTC: MUSLF) (FSE: 93X) ("Promino" or the "Company"), a developer of advanced proprietary amino... ► Artikel lesen | |
| ADDEX THERAPEUTICS | 0,049 | +6,59 % | Addex Therapeutics: Addex Announces Publication of Preclinical Data Supporting Potential of mGlu7 Negative Allosteric Modulators to Transform Anxiety and Fear-Related Disorder Treatment | Data published in Molecular Psychiatry
Ad Hoc Announcement Pursuant to Art. 53 LR
Geneva, Switzerland, February 3, 2026
-
Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage... ► Artikel lesen | |
| ARGENT BIOPHARMA | 0,011 | -8,33 % | ARGENT BIOPHARMA LIMITED: Completion of CannPal Asset Acquisition and Neuvis Option | ||
| CANNABIST COMPANY | 0,025 | -100,00 % | Cannabist Co Holdings Inc. - 8-K, Current Report | ||
| IANTHUS CAPITAL | 0,001 | 0,00 % | iAnthus Capital Holdings, Inc.: iAnthus Reports Fiscal Fourth Quarter and Full Year 2025 Financial Results | NEW YORK and TORONTO, March 27, 2026 (GLOBE NEWSWIRE) -- iAnthus Capital Holdings, Inc. ("iAnthus" or the "Company") (CSE: IAN, OTCID: ITHUF), which owns, operates, and partners with regulated cannabis... ► Artikel lesen | |
| CENTR BRANDS | 0,001 | 0,00 % | Centr Brands Corp (2): Centr Brands arranges $50,000 debenture financing | ||
| RESTART LIFE SCIENCES | 0,051 | 0,00 % | Restart Life Sciences Corp.: Restart Life Highlights Certified Manufacturing Platform to Drive Margin Expansion and Distribution Growth | Vancouver, British Columbia--(Newsfile Corp. - March 11, 2026) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") is pleased to provide investors... ► Artikel lesen | |
| AYR WELLNESS | 0,078 | -100,00 % | Ayr Wellness Inc.: AYR Wellness Announces Closing of Exit Facility and Related Transactions | MIAMI, April 10, 2026 (GLOBE NEWSWIRE) -- AYR Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) ("AYR" or the "Company"), a leading vertically integrated U.S. multi-state cannabis operator, announces the initial... ► Artikel lesen |
Das Unternehmen DICOT PHARMA AB kann der Branche Pharma zugeordnet werden. Die relative Kursveränderung beträgt aktuell +42,86 % bei einem Aktienkurs von 0,042 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu DICOT PHARMA AB finden Sie auf Wallstreet Online.